4//SEC Filing
Leverone Jason A. 4
Accession 0001415889-25-010418
CIK 0001637715other
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 5:30 PM ET
Size
7.8 KB
Accession
0001415889-25-010418
Insider Transaction Report
Form 4
Leverone Jason A.
Chief Financial Officer
Transactions
- Sale
Class A Common Stock
2025-04-07$2.67/sh−1,844$4,925→ 13,209 total - Sale
Class A Common Stock
2025-04-04$3.33/sh−1,278$4,253→ 15,053 total
Footnotes (4)
- [F1]These shares were automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"), pursuant to the terms of the Issuer's 2023 RSU Equity Incentive Plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $3.10 to $3.58. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F3]Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
- [F4]This transaction was executed in multiple trades at prices ranging from $2.57 to $3.03. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Documents
Issuer
OnKure Therapeutics, Inc.
CIK 0001637715
Entity typeother
Related Parties
1- filerCIK 0001692747
Filing Metadata
- Form type
- 4
- Filed
- Apr 7, 8:00 PM ET
- Accepted
- Apr 8, 5:30 PM ET
- Size
- 7.8 KB